NDC Package 73611-300-10 Qwo

Collagenase Clostridium Histolyticum-aaes Injection, Powder, Lyophilized, For Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73611-300-10
Package Description:
1 VIAL in 1 CARTON / 8 mL in 1 VIAL
Product Code:
Proprietary Name:
Qwo
Non-Proprietary Name:
Collagenase Clostridium Histolyticum-aaes
Substance Name:
Collagenase Clostridium Histolyticum
Usage Information:
QWO is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.
11-Digit NDC Billing Format:
73611030010
NDC to RxNorm Crosswalk:
  • RxCUI: 2475863 - collagenase clostridium histolyticum-aaes 0.92 MG Injection
  • RxCUI: 2475868 - Qwo 0.92 MG Injection
  • RxCUI: 2475868 - collagenase clostridium histolyticum-aaes 0.92 MG Injection [Qwo]
  • RxCUI: 2475870 - collagenase clostridium histolyticum-aaes 1.84 MG Injection
  • RxCUI: 2475872 - Qwo 1.84 MG Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Endo Aesthetics Llc
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intralesional - Administration within or introduced directly into a localized lesion.
  • Sample Package:
    No
    FDA Application Number:
    BLA761146
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    02-01-2021
    End Marketing Date:
    01-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    73611-300-051 VIAL in 1 CARTON / 4 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 73611-300-10?

    The NDC Packaged Code 73611-300-10 is assigned to a package of 1 vial in 1 carton / 8 ml in 1 vial of Qwo, a human prescription drug labeled by Endo Aesthetics Llc. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intralesional form.

    Is NDC 73611-300 included in the NDC Directory?

    Yes, Qwo with product code 73611-300 is active and included in the NDC Directory. The product was first marketed by Endo Aesthetics Llc on February 01, 2021.

    What is the 11-digit format for NDC 73611-300-10?

    The 11-digit format is 73611030010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-273611-300-105-4-273611-0300-10